Sarcopenia, which is characterized by decline in muscle mass, muscle strength, and
physical performance, is common in patients with chronic liver disease (CLD) and is …

End-stage liver disease (ESLD) is the culmination of progression of chronic liver disease to
cirrhosis, decompensation, and chronic liver failure, featuring portal hypertension or …

Background and Aim: Sarcopenia is considered an important risk factor for morbidity and
mortality in liver cirrhosis. Beta-hydroxy-beta-methylbutyrate (HMB) has the potential to …

Frailty represents a state of vulnerability to multiple internal physiologic factors, as well as
external pressures, and has been associated with clinical outcomes. We aim to understand …

The present review stresses goals of preventing frailty in ILD and preserving general health
and well being of people living with ILD of any age, from time of diagnosis and as they age …

Background and study aims: malnutrition and its clinical phenotypes, sarcopenia, and frailty,
are prevalent conditions that affect patients with cirrhosis awaiting liver transplantation. The …

This study investigated whether the progression of liver fibrosis affects the prevalence of
sarcopenia and incidence of decreased gait speed in older patients with chronic liver …

Саркопения—состояние прогрессирующей потери мышечной массы, наиболее
изучена у пациентов старческого возраста. Описывают саркопению у детей с …

Frailty corresponds to an emerging construct in the hepatology which is originally introduced
as a validated geriatric syndrome regarding increased vulnerability to pathophysiological …

Background Frailty is a common condition among patients with liver cirrhosis. Nonetheless,
its role in predicting liver transplant-free survival (TFS) remains unclear. Aim This systematic …